Roque Cardona-Hernandez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Roque Cardona-Hernandez has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Alberto Fernández
Servicio de Endocrinología y Nutrición, Hospital Universitario de Móstoles, Madrid, Spain; Sociedad Españnola de Endocrinología y Nutrición, Spain
2 shared publicationsAna Lucía Gómez Gila
Servicio de Endocrinología Pediátrica, Hospital Universitario Virgen del Rocío, Sevilla, Spain; Sociedad Españnola de Endocrinología Pediátrica, Spain
2 shared publicationsDídac Mauricio
Servicio de Endocrinología y Nutrición, CIBERDEM, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Sociedad Españnola de Diabetes, Spain
2 shared publicationsIgnacio Conget
Unidad de Diabetes, Servicio de Endocrinología y Nutrición, Hospital Clínic de Barcelona, Barcelona, Spain; Sociedad Españnola de Endocrinología y Nutrición, Spain
2 shared publicationsIsabel Leiva-Gea
Servicio de Endocrinología Pediátrica, Hospital Materno Infantil Regional de Málaga, Málaga. Instituto de Investigación Biomédica de Málaga (IBIMA)-Plataforma Bionand, Málaga, Spain; Sociedad Españnola de Endocrinología Pediátrica, Spain
2 shared publicationsLuis Castaño
Grupo de Endocrinología y Diabetes, Hospital Universitario Cruces, Universidad País Vasco UPV/EHU, IIS Biobizkaia, CIBERDEM/CIBERER, Endo-ERN, Bizkaia, Spain; Sociedad Españnola de Diabetes, Spain
2 shared publications
Latest Publications
- Open Access
- 20 November 2025
- Published by Elsevier in Anales de Pediatría (English Edition)
- Vol. 103 (5) , 503944
Executive summary. Screening, staging and follow-up of type 1 diabetes in preclinical stages: consensus of the scientific societies SED, SEEN and SEEP
- 20 November 2025
- Published by Elsevier in Anales de Pediatría (English Edition)
- Vol. 103 (5) , 503944
Open AccessExecutive summary. Screening, staging and follow-up of type 1 diabetes in preclinical stages: consensus of the scientific societies SED, SEEN and SEEP
- 18 October 2025
- Published by Elsevier in Endocrinología, Diabetes y Nutrición (English Ed.)
- Vol. 72 (9) , 501639
Executive summary. Screening, staging and follow-up of type 1 diabetes in preclinical stages: Consensus of the scientific societies SED, SEEN and SEEP
- 18 October 2025
- Published by Elsevier in Endocrinología, Diabetes y Nutrición (English Ed.)
- Vol. 72 (9) , 501639
Executive summary. Screening, staging and follow-up of type 1 diabetes in preclinical stages: Consensus of the scientific societies SED, SEEN and SEEP
- Open Access
- 26 July 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (15) , 4338
Increased Presentation of Diabetic Ketoacidosis and Changes in Age and Month of Type 1 Diabetes at Onset during the COVID-19 Pandemic in Spain
Objective: To assess the impact of the COVID-19 pandemic and lockdown measures on the presenting characteristics (age at diagnosis, severity, monthly distribution) of newly diagnosed type 1 diabetes in Spanish children. Research Design and Methods: An ambispective observational multicenter study was conducted in nine Spanish tertiary-level hospitals between January 2015 and March 2021. Inclusion criteria: new cases of type 1 diabetes in children (0–14 years) recording age, sex, date of diagnosis, presence of diabetic ketoacidosis (DKA) at onset, and severity of DKA. Data were compared before and during the pandemic. Results: We registered 1444 new cases of type 1 diabetes in children: 1085 in the pre-pandemic period (2015–2019) and 359 during the pandemic (2020–March 2021). There was a significant increase in the group aged ≤4 years in the pandemic period (chi-squared = 10.986, df 2, p = 0.0041). In 2020–2021, cases of DKA increased significantly by 12% (95% CI: 7.2–20.4%), with a higher percentage of moderate and severe DKA, although this increase was not significant. In 2020, there was a sharp decrease in the number of cases in March, with a progressive increase from May through November, higher than in the same months of the period 2015–2019, highlighting the increase in the number of cases in June, September, and November. The first three months of 2021 showed a different trend to that observed both in the years 2015–2019 and in 2020, with a marked increase in the number of cases. Conclusions: A change in monthly distribution was described, with an increase in DKA at onset of type 1 diabetes. No differences were found in severity, although there were differences in the age distribution, with an increase in the number of cases in children under 4 years of age.
- 26 July 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (15) , 4338
Open AccessIncreased Presentation of Diabetic Ketoacidosis and Changes in Age and Month of Type 1 Diabetes at Onset during the COVID-19 Pandemic in Spain
Objective: To assess the impact of the COVID-19 pandemic and lockdown measures on the presenting characteristics (age at diagnosis, severity, monthly distribution) of newly diagnosed type 1 diabetes in Spanish children. Research Design and Methods: An ambispective observational multicenter study was conducted in nine Spanish tertiary-level hospitals between January 2015 and March 2021. Inclusion criteria: new cases of type 1 diabetes in children (0–14 years) recording age, sex, date of diagnosis, presence of diabetic ketoacidosis (DKA) at onset, and severity of DKA. Data were compared before and during the pandemic. Results: We registered 1444 new cases of type 1 diabetes in children: 1085 in the pre-pandemic period (2015–2019) and 359 during the pandemic (2020–March 2021). There was a significant increase in the group aged ≤4 years in the pandemic period (chi-squared = 10.986, df 2, p = 0.0041). In 2020–2021, cases of DKA increased significantly by 12% (95% CI: 7.2–20.4%), with a higher percentage of moderate and severe DKA, although this increase was not significant. In 2020, there was a sharp decrease in the number of cases in March, with a progressive increase from May through November, higher than in the same months of the period 2015–2019, highlighting the increase in the number of cases in June, September, and November. The first three months of 2021 showed a different trend to that observed both in the years 2015–2019 and in 2020, with a marked increase in the number of cases. Conclusions: A change in monthly distribution was described, with an increase in DKA at onset of type 1 diabetes. No differences were found in severity, although there were differences in the age distribution, with an increase in the number of cases in children under 4 years of age.